FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel N-substituted azaheterocyclic carboxylic acid of the formula (I) or their salts where R1 and R2 mean independently hydrogen, halogen atom, trifluoromethyl-group, C1-C6-alkyl or C1-C6-alkoxy-group; Y means groups or =CH where underlined atom takes part in cyclic system; X means groups -O-, -S-, -CR7R8-, -CH2-CH2-, -CH= CH--CH2-, -CH2-CH= CH-, -CH2CH2CH2-, -CH= CH-, -NR9-(C=O)-, -O-CH2-, -(C=O)- or -(S=O)- where R7, R8, R9 mean independently hydrogen atom or C1-C6-alkyl; r = 1, 2 or 3; M = 1 or 2; n = 1 when m = 1 and n = 0 when m = 2; R4 and R5 each means hydrogen atom or when m = 2 then both in common can form a bond; R6 is hydroxyl or C1-C8-alkoxy-group, or its pharmaceutically acceptable salt under condition that compounds 10-[3-(3-carbomethoxy-1-piperidyl)-propyl} -phenothiazine and 10-[3-(3-carbohexoxy-1-piperidyl)-propyl] -phenothiazine are not included. Compounds of the formula (I) inhibit neurogenic inflammation and can be used in medicine. Invention describes also method of synthesis of compounds of the formula (I), pharmaceutical composition and method of inhibition of neurogenic inflammation. EFFECT: improved method of synthesis, valuable medicinal properties. 9 cl, 2 tbl, 18 ex
Title |
Year |
Author |
Number |
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND PHARMACEUTICAL COMPOSITION |
1997 |
- Andersen Khenrik Sune
- Jergensen Tine Krog
- Khol'Veg Rol'F
- Andersen Knud Ehrik
- Polivka Zdenek
|
RU2186769C2 |
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND THEIR ESTERS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITION OF NEUROGENOUS PAIN, INFLAMMATION AND BLOOD GLUCOSE LEVEL IN PATIENT |
1996 |
- Florentsio Zaragossa Dervall'
- Knud Ehrik Andersen
- Peter Madsen
- Tine Krokh Jorgensen
- Rol'F Khol'Vaj
- Khenrik Sune Andersen
- Svenn Treppendal'
- Uffe Bang Ol'Sen
- Zdenek Polivka
- Aleksandra Silgankova
- Karel Sindelar
|
RU2244713C2 |
1,4-DISUBSTITUTED PIPERAZINES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF NEUROGENIC INFLAMMATION |
1997 |
- Khol'Veg Rol'F
- Madsen Peter
- Jergensen Tine Krog
- Andersen Knud Ehrik
- Vatson Brett
- Polivka Zdenek
- Konigova Otilie
- Sil'Gankova Aleksandra
- Valenta Vladimir
|
RU2188197C2 |
DERIVATIVES OF DIBENZO[D,G][1,3]DIOXOCINE AND DIBENZO[D,G]- [1,3,6]DIOXAZOCINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT OF NEUROGENIC INFLAMMATION, NEUROPATHY AND RHEUMATIC ARTHRITIS |
1996 |
- Rol'F Khol'Vaj
- Tine Krog Jergensen
- Knud Ehrik Andersen
- Uffe Bang Ol'Sen
- Peter Madsen
- Zendek Polivka
- Otil'E Kenigova
- Aleksandra Silkhankova
- Karel Sindelar
|
RU2178790C2 |
DERIVATIVES OF [1,2,4]-TRIAZOLO-[4,3-A]-QUINOXALINONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF AMPA- -RECEPTORS |
1995 |
- Nel'Sen Flemming Ehl'Melund
|
RU2149162C1 |
2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND METHODS OF SYNTHESIS |
1993 |
- Kristian Foged
- Rol'F Kholveg
- Ehrik Bardrum Nil'Sen
|
RU2114839C1 |
TRICYCLIC DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND METHOD OF INHIBITION OF VASOPRESSINE |
1994 |
- Dzhej D. Olbrajt
- Mehrvin F. Rejch
- Fuk-Vakh Sam
- Ksjumej Du
|
RU2149160C1 |
3-(1,2,5-OXADIAZOLE-3-YL)- OR 3-(1,2,5-THIADIAZOLE-3-YL)-1,2,5,6-TETRAHYDROPYRIDINE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND PHARMACEUTICAL COMPOSITION SHOWING MUSCARINIC, CHOLINERGIC, RECEPTOR AGONISTIC ACTIVITY |
1990 |
- Per Sauehrberg[Dk]
- Preben Khoulberg Olesen[Dk]
|
RU2042676C1 |
SUBSTITUTED PYRAZOLOAZEPINE-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |
2017 |
- Lyan, Sifu
- Larsen, Jens
- Nilsen, Simon Feldbek
- Andersen, Peter
|
RU2768746C2 |
SUBSTITUTED PYRAZOLOAZEPINE-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |
2016 |
- Lyan, Sifu
- Larsen, Jens
- Nilsen, Simon Feldbek
- Andersen, Peter
|
RU2762279C2 |